Journal article Open Access
Wu, Kuei-Meng; Farrelly, James G.
<?xml version='1.0' encoding='utf-8'?> <oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"> <dc:creator>Wu, Kuei-Meng</dc:creator> <dc:creator>Farrelly, James G.</dc:creator> <dc:date>2007-07-01</dc:date> <dc:description>n/a</dc:description> <dc:identifier>https://zenodo.org/record/1259393</dc:identifier> <dc:identifier>10.1016/j.tox.2007.04.005</dc:identifier> <dc:identifier>oai:zenodo.org:1259393</dc:identifier> <dc:rights>info:eu-repo/semantics/openAccess</dc:rights> <dc:rights>https://creativecommons.org/publicdomain/zero/1.0/legalcode</dc:rights> <dc:title>Regulatory perspectives of Type II prodrug development and time-dependent toxicity management: Nonclinical Pharm/Tox analysis and the role of comparative toxicology</dc:title> <dc:type>info:eu-repo/semantics/article</dc:type> <dc:type>publication-article</dc:type> </oai_dc:dc>
Views | 488 |
Downloads | 595 |
Data volume | 100.1 MB |
Unique views | 477 |
Unique downloads | 566 |